Is Jupiter Life Line Hospitals a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Jupiter Life Line Hospitals Ltd is a good quality company .

Is Jupiter Life Line Hospitals undervalued or overvalued?

The key valuation ratios of Jupiter Life Line Hospitals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Jupiter Life Line Hospitals share price return in the past 10 years?

Data is not available for this company

Is Jupiter Life Line Hospitals a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Jupiter Life Line Hospitals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Jupiter Life Line Hospitals?

The latest standalone P/E ratio of Jupiter Life Line Hospitals as of 18-Jul-2025 is 53.05.

What is the P/B ratio of Jupiter Life Line Hospitals?

The latest standalone P/B ratio of Jupiter Life Line Hospitals as of 18-Jul-2025 is 6.89.

What is the 52-week high and low of Jupiter Life Line Hospitals?

The 52-week high of Jupiter Life Line Hospitals is Rs. 1759.00 and the 52-week low is Rs. 1250.00.

Jupiter Life Line Hospitals Ltd - Stock Valuation and Financial Performance

Name: Jupiter Life Line Hospitals
Brand: Jupiter Life Line Hospitals

BSE: 543980 | NSE: JLHL | Hospital & Healthcare Services | Small Cap

Place order

Jupiter Life Line Share Price

₹1,490.70 -3.60 -0.24%
as on 18-Jul'25 16:59

Jupiter Life Line Hospitals Ltd - Stock Valuation and Financial Performance

BSE: 543980 | NSE: JLHL | Hospital & Healthcare Services | Small Cap

Place order

Jupiter Life Line Share Price

₹1,490.70 -3.60 -0.24%
as on 18-Jul'25 16:59

10 Year X-Ray of Jupiter Life Line:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	23.9%	17.2%	10.4%	10%	12.1%	9%	23.2%	26.4%	22.2%	18.6%	-
Value Creation Index ⓘ	0.8	0.3	-0.2	-0.3	-0.1	-0.3	0.7	1.0	0.6	0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	251	264	320	399	463	461	657	787	915	1,060	1,060
Sales YoY Gr.	-	5.4%	21.3%	24.4%	16.2%	-0.4%	42.6%	19.8%	16.2%	15.9%	-
Adj EPS ⓘ	6.2	5.8	5.9	3.6	5.8	3.3	16.6	19.2	23.2	27.7	28.2
YoY Gr.	-	-6.8%	1.6%	-39.5%	63.5%	-44%	409.2%	15.7%	20.7%	19.5%	-
BVPS (₹) ⓘ	27.9	33.7	39	41.9	46.5	49.8	64.3	82.3	189.9	217	217
Adj Net Profit ⓘ	31.1	29.3	29.9	18.1	29.6	16.6	84.5	109	152	182	185
Cash Flow from Ops. ⓘ	49.9	62.7	43.5	45.6	74.6	113	142	184	110	220	-
Debt/CF from Ops. ⓘ	2.3	3	4.8	5.5	3.5	2.3	2.3	1.6	0	0.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	17.4%	18%	17.3%	15.9%
Adj EPS ⓘ	18.1%	36.6%	18.6%	19.5%
BVPSⓘ	25.6%	36.1%	50%	14.2%
Share Price	-	-	-	13.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	25.3	18.9	16.2	8.8	13.2	6.8	29	27.4	17.8	13.6	13
Op. Profit Mgn % ⓘ	24.4	23.3	17	16.3	17.6	14.6	24.2	25.9	24.9	25.4	25.1
Net Profit Mgn % ⓘ	12.4	11.1	9.3	4.5	6.4	3.6	12.9	13.8	16.6	17.1	17.4
Debt to Equity ⓘ	0.8	1.1	1.1	1.2	1.1	1	1	0.6	0	0.1	0.1
Working Cap Days ⓘ	53	50	54	65	88	91	54	62	115	95	88
Cash Conv. Cycle ⓘ	-37	-42	-41	-28	-29	-36	-35	-32	-23	-26	69

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 17.27%

Net Profit is growing at healthy rate in last 3 years 18.60%

Sales growth is good in last 4 quarters at 15.89%

Return on Equity has declined versus last 3 years average to 13.00%

Latest Financials - Jupiter Life Line Hospitals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	28.2	29.3
TTM Sales (₹ Cr.)	1,060	1,262
BVPS (₹.) ⓘ	217	206.9
Reserves (₹ Cr.) ⓘ	1,357	1,291
P/BV ⓘ	6.89	7.22
PE ⓘ	53.05	50.94

From the Market
52 Week Low / High (₹)	1250.00 / 1759.00
All Time Low / High (₹)	960.00 / 1759.00
Market Cap (₹ Cr.)	9,798
Equity (₹ Cr.)	65.6
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of Jupiter Life Line:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Jupiter Life Line

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Jupiter Life Line

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	251	264	320	399	463	461	657	787	915	1,060
Operating Expenses ⓘ	189	203	266	334	382	394	498	583	687	791
Manufacturing Costs	15	17	23	51	61	56	67	89	95	110
Material Costs	49	50	60	81	80	94	127	135	159	191
Employee Cost	37	43	67	82	93	100	114	129	159	177
Other Costs ⓘ	88	93	116	120	148	143	190	230	275	313
Operating Profit ⓘ	61	62	54	65	81	68	159	204	227	269
Operating Profit Margin (%)	24.4%	23.3%	17.0%	16.3%	17.6%	14.6%	24.2%	25.9%	24.9%	25.4%
Other Income ⓘ	2	3	5	3	3	6	4	13	26	28
Interest ⓘ	8	8	16	24	26	28	29	28	19	9
Depreciation ⓘ	11	12	20	24	26	27	28	29	31	42
Exceptional Items ⓘ	0	0	0	0	0	0	0	-2	0	0
Profit Before Tax ⓘ	45	45	24	20	33	18	106	159	204	246
Tax ⓘ	14	15	-6	2	3	1	21	52	52	62
Profit After Tax	31	29	30	18	30	17	85	107	152	185
PAT Margin (%)	12.4%	11.1%	9.3%	4.6%	6.4%	3.6%	12.9%	13.6%	16.6%	17.4%
Adjusted EPS (₹)	6.2	5.8	5.9	3.6	5.8	3.3	16.7	19.0	23.2	28.2
Dividend Payout Ratio (%)	8%	9%	9%	28%	0%	0%	6%	5%	4%	4%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund	140	170	198	213	237	253	327	465	1,245	1,423
Share Capital ⓘ	50	51	51	51	51	51	51	57	66	66
Reserves ⓘ	90	120	147	162	186	202	276	409	1,180	1,357
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	104	180	197	241	254	250	319	295	0	74
Long Term Debt	88	177	186	234	244	258	298	295	0	74
Short Term Debt	16	3	11	7	10	-9	21	0	0	0
Trade Payables	18	28	37	37	59	50	54	62	51	82
Others Liabilities ⓘ	37	41	38	45	44	63	55	63	65	131
Total Liabilities ⓘ	298	420	470	537	594	615	755	885	1,361	1,710
Fixed Assets
Gross Block	224	319	471	547	576	595	660	700	731	977
Accumulated Depreciation	61	73	93	116	141	168	195	224	254	264
Net Fixed Assetsⓘ	163	246	379	431	435	426	465	476	477	713
CWIP ⓘ	92	132	28	12	11	13	14	16	61	163
Investmentsⓘ	1	1	1	2	2	65	71	95	111	208
Inventories	6	6	10	10	14	12	13	15	17	18
Trade Receivables	12	13	18	26	45	20	28	40	46	37
Cash Equivalents ⓘ	6	3	4	8	7	19	102	133	297	488
Others Assetsⓘ	18	17	31	48	81	59	62	108	351	84
Total Assets ⓘ	298	420	470	537	594	615	755	885	1,361	1,710

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ	50	63	43	46	75	113	142	184	110	220
PBT ⓘ	45	45	24	20	33	18	106	159	204	246
Adjustment ⓘ	19	18	31	45	66	54	54	49	25	24
Changes in Working Capital ⓘ	-2	9	-0	-5	-9	51	-9	10	-69	12
Tax Paid ⓘ	-8	-9	-11	-14	-15	-10	-9	-33	-50	-62
Cash Flow From Investing Activity ⓘ	-76	-133	-43	-58	-43	-78	-69	-130	-238	-173
Capex	-77	-135	-48	-60	-29	-22	-66	-43	-76	-280
Net Investments	0	0	0	1	0	-57	-5	-34	-185	87
Others ⓘ	1	2	5	1	-15	1	2	-52	23	20
Cash Flow From Financing Activityⓘ	28	68	1	16	-32	-23	10	-23	122	302
Net Proceeds from Shares ⓘ	5	2	1	0	0	0	2	34	633	0
Net Proceeds from Borrowing ⓘ	0	0	0	47	7	18	31	-3	-295	75
Interest Paid ⓘ	-8	-8	-16	-24	-26	-28	-29	-28	-19	-17
Dividend Paid ⓘ	84	-3	-3	-3	-5	0	0	-5	-6	-7
Others ⓘ	-53	77	18	-4	-9	-13	7	-21	-192	250
Net Cash Flow ⓘ	2	-3	1	3	-1	12	84	31	-6	348

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	25.3	18.89	16.23	8.82	13.17	6.77	29.18	27.07	17.77	13.85
ROCE (%)	23.94	17.19	10.42	9.95	12.14	9.01	23.15	26.4	22.16	18.59
Asset Turnover Ratio	0.95	0.74	0.72	0.79	0.82	0.76	0.96	0.96	0.81	0.69
PAT to CFO Conversion(x)	1.61	2.17	1.43	2.56	2.5	6.65	1.67	1.72	0.72	1.19
Working Capital Days
Receivable Days	17	17	18	20	28	26	13	16	17	14
Inventory Days	8	8	9	9	10	10	7	7	6	6
Payable Days	141	167	196	167	219	210	149	157	130	127

Jupiter Life Line Hospitals Ltd Stock News

Jupiter Life Line Hospitals Ltd FAQs

What is the share price of Jupiter Life Line?

Company share prices are keep on changing according to the market conditions. The closing price of Jupiter Life Line on 18-Jul-2025 16:59 is ₹1,490.7.

What is the market cap of Jupiter Life Line?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Jul-2025 16:59 the market cap of Jupiter Life Line stood at ₹9,797.5.

What is the P/E ratio of Jupiter Life Line?

The latest P/E ratio of Jupiter Life Line as of 18-Jul-2025 16:59 is 53.05.

What is the P/B ratio of Jupiter Life Line?

The latest P/B ratio of Jupiter Life Line as of 18-Jul-2025 16:59 is 6.89.

What is the 52-week high and low of Jupiter Life Line?

The 52-week high of Jupiter Life Line is ₹1,759 and the 52-week low is ₹1,250.

What is the TTM revenue of Jupiter Life Line?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jupiter Life Line is ₹1,060 ( Cr.) .

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals was incorporated in Mumbai, Maharashtra, as ‘Jupiter Life Line Hospitals Limited’, a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2002, issued by the RoC. The company commenced its business on December 24, 2002. The company is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India. It has been operating for many years as a corporate quaternary care healthcare service provider in densely populated micro markets in the western regions of India and currently operate three hospitals under the ‘Jupiter’ brand in Thane, Pune and Indore. It is also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate many beds.

The company commenced operations in 2007 with its hospital in Thane, Maharashtra and subsequently scaled its operations by setting up a hospital in Pune, Maharashtra in 2017 and acquiring a hospital in Indore, Madhya Pradesh in 2020. Its hospitals are also located in densely populated micro markets which have a low presence of chained hospitals, which provides it an opportunity to offer its services to a larger population and helps its patients with greater access and connectivity to healthcare services. Its hospitals function on an ‘all-hub-no-spoke’ model with each hospital being a full-service hospital, operating independently and serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. Its Thane and Pune hospitals are ‘greenfield’ projects, and all three of its hospitals are located on land owned by it on a freehold basis, which ensures operational control and allows it consistency in quality care resulting in long-term operational and financial efficiencies.

Business area of the company

The company is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare providers.

Awards

2018: Awarded the Best Multispecialty hospital in Thane District at the NavBharat Healthcare Excellence Awards.
2019: Awarded the Hospital of the year - India at the Healthcare Asia Awards.
2019: Awarded for outstanding contribution in charitable healthcare at the Star of the Industry Awards.
2019: Received the award for best design in healthcare for its Indore Hospital, at the Healthcare Leadership Awards.
2021: Recognized for excellence in change management for its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
2021: Winner of the award for excellence in workplace management for the human resources department of its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
2021: Received the Silver award - Covid Protection Project at the IHW Awards.
2022: Received the NEERMAN award in the healthcare category for its Pune Hospital.
2022: Received the milestone merits 2022 - safety award from the IMC Ramkrishna Bajaj National Quality Trust.
2023: Awarded the certificate of excellence for its Indore Hospital for being the cleanest hospital in Indore at the Swachh Ward Rankings.
2023: Awarded the Maharashtra state best employer brand award, 2023 at the 18th Employer Branding Awards.

Accreditations and recognitions

2020: Accreditation for its Thane Hospital by the National Accreditation Board for Hospital & Healthcare Providers.
2020: Accreditation for its Pune Hospital, Maharashtra by the National Accreditation Board for Hospital & Healthcare Providers.
2021: Accreditation for its Indore Hospital, Madhya Pradesh by the National Accreditation Board for Hospital & Healthcare Providers.
2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Pune Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Thane Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
2023: ISO 22000:2018 accreditation for food safety and management system for the Fortune Park Lake City hotel at Thane by the Standards Council of Canada.

History and milestones

2007: Established and commenced operations of its first hospital at Thane, Maharashtra.
2017: Established and commenced operations of its Pune Hospital.
2018: Carried out interstitial brachytherapy to treat cancer at its Thane Hospital.
2020: Acquired its Indore Hospital.
2021: Successfully carried out small bowel intestine transplant surgery at its Thane, Hospital.
2022: Successfully carried out heart transplant surgery at its Thane Hospital.

SEBI Registered: Investment Adviser - INA000013323 RIA Details

Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.

Compliance Officer:

Name: Shrikant Jagtap

Email: shrikant.jagtap@moneyworks4me.com

Mobile No: +91 97638 00745

Grievance Officer:

Name: Mukta Vaze

Email: mukta.vaze@moneyworks4me.com

Mobile No:+91 98609 19463

Principal Officer:

Name: Atharva Bhide

Email: atharva.bhide@moneyworks4me.com

Mobile No:+91 91758 99463

SEBI regional/local office address-

Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051

Address:

The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Data provided by Accord Fintech Pvt. Ltd.

Please wait your portfolio is updating...

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity - May 16, 2019 - Perpetual
BASL Membership ID:	BASL1187
Address	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Jupiter Life Line Hospitals Ltd - Stock Valuation and Financial Performance

Jupiter Life Line Share Price

Jupiter Life Line Hospitals Ltd - Stock Valuation and Financial Performance

Jupiter Life Line Share Price

DeciZen - make an informed investing decision on Jupiter Life Line Share

Overall Rating ⓘ

1. Quality

2. Valuation ⓘ

3. Price Trend

Jupiter Life Line Hospitals stock performance -

Is Jupiter Life Line Hospitals Ltd an attractive stock to invest in?

1. Is Jupiter Life Line Hospitals Ltd a good quality company?

2. Is Jupiter Life Line Hospitals Ltd undervalued or overvalued?

3. Is Jupiter Life Line Hospitals Ltd a good buy now?

10 Year X-Ray of Jupiter Life Line: Share

Analysis of Financial Track Record

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Recent Performance Summary

Latest Financials - Jupiter Life Line Hospitals Ltd.

Management X-Ray of Jupiter Life Line: Share

Shareholding Pattern

Promoter's Holding & Share Pledging